{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:33:51Z","timestamp":1789893231006,"version":"4.0.1"},"reference-count":0,"publisher":"Clinical Laboratory Publications","issue":"03\/2014","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Lab."],"published-print":{"date-parts":[[2014]]},"DOI":"10.7754\/clin.lab.2013.130642","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T12:49:12Z","timestamp":1381754952000},"source":"Crossref","is-referenced-by-count":22,"title":["Anti-IgE Monoclonal Antibody (Omalizumab) is effective in Treating Bullous Pemphigoid and Its Effects on Soluble CD200"],"prefix":"10.7754","volume":"60","author":[{"given":"Arzu","family":"Yalcin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Genc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadet","family":"Gumuslu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4487","container-title":["Clinical Laboratory"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T08:30:26Z","timestamp":1487147426000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.clin-lab-publications.com\/article\/1451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":0,"journal-issue":{"issue":"03\/2014","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.7754\/clin.lab.2013.130642","relation":{},"ISSN":["1433-6510"],"issn-type":[{"value":"1433-6510","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}